[1]
Botsios, C. et al. 2007. Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis. Reumatismo. 59, 1 (Mar. 2007), 32–37. DOI:https://doi.org/10.4081/reumatismo.2007.32.